CytomX Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 08/14/2025 | 11.07 M | $25.12 M | 64.72% | 12.70% |
| VR ADVISER, LLC | 08/14/2025 | 13.97 M | $31.71 M | 100.00% | 10.82% |
| VANGUARD GROUP INC | 08/11/2025 | 9.38 M | $21.29 M | 83.29% | 10.77% |
| FMR LLC | 08/14/2025 | 9.24 M | $20.97 M | 8,429.94% | 10.60% |
| COMMODORE CAPITAL LP | 08/14/2025 | 7.69 M | $17.46 M | 100.00% | 8.83% |
| FRANKLIN RESOURCES INC | 08/12/2025 | 5.77 M | $13.10 M | 100.00% | 6.62% |
| ORBIMED ADVISORS LLC | 08/14/2025 | 8.46 M | $19.21 M | 100.00% | 6.56% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2025 | 8.08 M | $18.35 M | 205.08% | 6.26% |
| PERCEPTIVE ADVISORS LLC | 08/14/2025 | 6.99 M | $15.88 M | 100.00% | 5.42% |
| VIVO CAPITAL, LLC | 08/14/2025 | 5.77 M | $13.10 M | 100.00% | 4.47% |
| BAKER BROS. ADVISORS LP | 08/14/2025 | 3.48 M | $7.91 M | 100.00% | 4.00% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2025 | 2.87 M | $6.50 M | 100.00% | 3.29% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2025 | 3.90 M | $8.85 M | 100.00% | 3.02% |
| PROSIGHT MANAGEMENT, LP | 08/14/2025 | 3.52 M | $7.98 M | -10.51% | 2.72% |
| WOODLINE PARTNERS LP | 08/14/2025 | 2.34 M | $5.30 M | 41.01% | 2.68% |
| RTW INVESTMENTS, LP | 08/14/2025 | 3.46 M | $7.86 M | 100.00% | 2.68% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 3.08 M | $6.99 M | 6,451.18% | 2.39% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 1.86 M | $4.23 M | 61.09% | 2.14% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2025 | 2.66 M | $6.04 M | 166.13% | 2.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 1.75 M | $3.96 M | 103.41% | 2.00% |
| BLACKROCK, INC. | 08/12/2025 | 2.39 M | $5.42 M | 104.77% | 1.85% |
| MARSHALL WACE, LLP | 08/13/2025 | 2.35 M | $5.34 M | 2,650.93% | 1.82% |
| KYNAM CAPITAL MANAGEMENT, LP | 08/14/2025 | 2.15 M | $4.89 M | 100.00% | 1.67% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/15/2025 | 1.30 M | $2.96 M | 100.00% | 1.50% |
| ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 1.56 M | $3.53 M | -51.85% | 1.21% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/11/2025 | 720.02 K | $1.63 M | 1.20% | 0.83% |
| STATE STREET CORP | 08/14/2025 | 639.04 K | $1.45 M | 99.67% | 0.73% |
| GSA CAPITAL PARTNERS LLP | 07/22/2025 | 630.81 K | $1.43 M | -17.32% | 0.72% |
| READYSTATE ASSET MANAGEMENT LP | 08/07/2025 | 844.64 K | $1.92 M | 100.00% | 0.65% |
| NORTHERN TRUST CORP | 08/13/2025 | 450.11 K | $1.02 M | 198.81% | 0.52% |
| UBS GROUP AG | 08/14/2025 | 408.04 K | $926.24 K | -45.36% | 0.47% |
| TOROSO INVESTMENTS, LLC | 08/14/2025 | 312.85 K | $710.17 K | -11.58% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 291.90 K | $662.60 K | 915.86% | 0.34% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 283.56 K | $643.68 K | 100.00% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 08/05/2025 | 252.66 K | $573.54 K | 4.41% | 0.29% |
| ROYAL BANK OF CANADA | 08/14/2025 | 243.55 K | $552.00 K | 100.00% | 0.28% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 233.34 K | $529.68 K | -91.74% | 0.27% |
| FORMIDABLE ASSET MANAGEMENT, LLC | 07/16/2025 | 312.85 K | $710.17 K | -11.58% | 0.24% |
| LPL FINANCIAL LLC | 08/12/2025 | 201.22 K | $456.78 K | 375.54% | 0.23% |
| DIMENSIONAL FUND ADVISORS LP | 08/12/2025 | 183.17 K | $415.79 K | 100.00% | 0.21% |
| EAM INVESTORS, LLC | 08/12/2025 | 254.58 K | $577.90 K | 100.00% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 157.68 K | $357.94 K | 35.38% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2025 | 126.00 K | $286.02 K | -58.91% | 0.14% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2025 | 88.57 K | $201.05 K | 256.03% | 0.10% |
| XTX TOPCO LTD | 08/12/2025 | 121.90 K | $276.71 K | 100.00% | 0.09% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2025 | 75.00 K | $170.25 K | 0.00% | 0.09% |
| ASPIRE GROWTH PARTNERS LLC | 08/13/2025 | 102.25 K | $232.12 K | 10.84% | 0.08% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2025 | 99.41 K | $225.66 K | 100.00% | 0.08% |
| CONGRESS PARK CAPITAL LLC | 07/11/2025 | 95.42 K | $216.61 K | -85.84% | 0.07% |
| JANE STREET GROUP, LLC | 08/14/2025 | 62.60 K | $142.10 K | 100.00% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 729,967
Inspire Investing, LLC: 522,482
Bank of New York Mellon Corp: 252,659
Precision Wealth Strategies, LLC: 237,081
Formidable Asset Management, LLC: 118,337
Congress Park Capital LLC: 103,922
103.28% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 137.44 M shares in the last 24 months. This purchase volume represents approximately $483.79 M in transactions.